Semprus, Nara, UberSense, & More Names from the Boston Deal Roundup

This week’s deal headlines show a healthy mix of startup funding, acquisitions, and IPO news across both the tech and healthcare industries.

—PatientKeeper, a Waltham, MA-based maker of software for physician workflow, said it raised $6.25 million from existing investors like Flybridge Capital Partners, New Enterprise Associates, and Whitney & Co. The money comes atop a $6 million cash infusion from last December, and will go toward expanding services and meeting hospitals’ demand for other clinical and financial software applications.

—The Needham, MA-based advertising optimization software maker Visual IQ inked a $12 million Series B investment, from Volition Capital and return backer Fog City Capital.

—Semprus Biosciences, a spinout from the lab of prolific MIT inventor Bob Langer, was acquired by the Pennsylvania-based medical devices company Teleflex (NASDAQ: TFX) for an upfront payment of $30 million. That’s just slightly more than the total raised by Semprus, which develops surface technologies for devices that can help prevent infections or unhealthy blood clots, or promote tissue regeneration. The parent company may pay more over the next few years based on certain regulatory and revenue milestones.

—Cambridge- and Menlo Park, CA-based Charles River Ventures joined a syndicate of Silicon Valley venture investors in a $1.4 million seed funding round for Palo Alto, CA-based Freshplum, a newly de-stealthed company working on analytics technology to help guide company pricing decisions.

—On the East Coast, Web startup Nara Logics also came out of stealth mode and announced a $4 million funding round from Peter de Roetth and other angel investors. The Cambridge-based company also launched the public beta version of its online personalized consumer search engine.

—A couple of Boston-area companies are set to make their debut on the public markets this week: Waltham-based cancer drug developer Tesaro, looking to sell 6 million shares at $12 to $15 apiece, and Exa, a Burlington, MA-based maker of software for vehicle simulations. Exa hopes to sell 6.25 million shares at $11 to $13 each.

—An SEC filing from earlier this week shows that Cambridge-based UberSense, a TechStars Boston 2012 graduate that uses mobile and video tech to connect athletes and coaches, has raised $1.15 million in an equity round from 15 investors.

Trending on Xconomy